GDTC
USDCytoMed Therapeutics Limited Ordinary Shares
$1.990-0.070 (-3.398%)
Real-time Price
Healthcare
Biotechnology
Singapore
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.060
High
$2.060
Low
$1.920
Volume
0.00M
Company Fundamentals
Market Cap
23.4M
Industry
Biotechnology
Country
Singapore
Trading Stats
Avg Volume
0.07M
Exchange
NCM
Currency
USD
52-Week Range
Low $1.65Current $1.990High $4.05
Related News
GlobeNewswire
Update on recent acquisition - CytoMed Therapeutics expands into auto-immune diseases building on its recent cord blood bank acquisition
SINGAPORE, Aug. 28, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "Company"), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary
View more
GlobeNewswire
CytoMed Therapeutics Limited Announces At-the-Market (ATM) Offering Program
SINGAPORE, Aug. 18, 2025 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ:GDTC) ("CytoMed" or "Company"), a Singapore-based clinical stage biopharmaceutical company focused on harnessing its proprietary
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.